Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Natriuretic Peptides | 3 | 2018 | 8 | 1.130 |
Why?
|
| Pediatric Obesity | 3 | 2024 | 109 | 1.030 |
Why?
|
| Receptors, Peptide | 3 | 2023 | 34 | 1.020 |
Why?
|
| Pediatricians | 2 | 2017 | 52 | 1.000 |
Why?
|
| Appointments and Schedules | 2 | 2017 | 60 | 0.910 |
Why?
|
| Receptors, Guanylate Cyclase-Coupled | 3 | 2023 | 6 | 0.860 |
Why?
|
| Infant | 8 | 2023 | 1645 | 0.810 |
Why?
|
| Intestines | 1 | 2023 | 165 | 0.730 |
Why?
|
| Plagiocephaly | 1 | 2021 | 6 | 0.700 |
Why?
|
| Plagiocephaly, Nonsynostotic | 1 | 2021 | 5 | 0.690 |
Why?
|
| Quality Improvement | 2 | 2017 | 443 | 0.680 |
Why?
|
| Microbiota | 1 | 2022 | 129 | 0.650 |
Why?
|
| Fatty Liver | 1 | 2021 | 108 | 0.640 |
Why?
|
| Health Services Accessibility | 2 | 2016 | 564 | 0.630 |
Why?
|
| Hospitals, Pediatric | 2 | 2017 | 52 | 0.630 |
Why?
|
| Satiation | 1 | 2018 | 5 | 0.570 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2022 | 236 | 0.560 |
Why?
|
| Intestinal Perforation | 1 | 2017 | 17 | 0.530 |
Why?
|
| Abdominal Wall | 1 | 2017 | 23 | 0.530 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2017 | 40 | 0.520 |
Why?
|
| Intestinal Mucosa | 2 | 2017 | 242 | 0.510 |
Why?
|
| Foreign Bodies | 1 | 2017 | 55 | 0.510 |
Why?
|
| Colon | 1 | 2017 | 147 | 0.490 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 183 | 0.460 |
Why?
|
| Child | 8 | 2024 | 4526 | 0.460 |
Why?
|
| Ambulatory Care | 1 | 2017 | 311 | 0.450 |
Why?
|
| Child, Preschool | 5 | 2023 | 1990 | 0.410 |
Why?
|
| Waiting Lists | 1 | 2013 | 52 | 0.400 |
Why?
|
| Attitude of Health Personnel | 2 | 2023 | 598 | 0.390 |
Why?
|
| Referral and Consultation | 1 | 2016 | 422 | 0.390 |
Why?
|
| Gastroenterology | 1 | 2013 | 42 | 0.380 |
Why?
|
| Gastrointestinal Diseases | 1 | 2013 | 71 | 0.380 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 435 | 0.370 |
Why?
|
| Primary Health Care | 4 | 2023 | 690 | 0.350 |
Why?
|
| Adolescent | 7 | 2024 | 6245 | 0.350 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 712 | 0.340 |
Why?
|
| Biomarkers | 3 | 2024 | 1408 | 0.340 |
Why?
|
| Bronchomalacia | 1 | 2008 | 2 | 0.290 |
Why?
|
| Immunohistochemistry | 2 | 2023 | 896 | 0.290 |
Why?
|
| Bronchi | 1 | 2008 | 81 | 0.280 |
Why?
|
| Aorta, Thoracic | 1 | 2008 | 84 | 0.280 |
Why?
|
| Humans | 17 | 2024 | 63445 | 0.280 |
Why?
|
| Aneurysm, False | 1 | 2008 | 52 | 0.280 |
Why?
|
| Infant, Newborn | 3 | 2023 | 1358 | 0.270 |
Why?
|
| Receptors, Enterotoxin | 3 | 2023 | 6 | 0.260 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1119 | 0.220 |
Why?
|
| Acetylcysteine | 1 | 2024 | 26 | 0.220 |
Why?
|
| Stents | 1 | 2008 | 502 | 0.220 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2024 | 13 | 0.220 |
Why?
|
| Female | 9 | 2024 | 32880 | 0.220 |
Why?
|
| Vancomycin | 1 | 2024 | 39 | 0.210 |
Why?
|
| Vision Screening | 1 | 2023 | 9 | 0.200 |
Why?
|
| Microvilli | 1 | 2023 | 5 | 0.200 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2024 | 90 | 0.200 |
Why?
|
| Guanylate Cyclase | 2 | 2001 | 10 | 0.200 |
Why?
|
| Delphi Technique | 1 | 2023 | 101 | 0.200 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2024 | 102 | 0.190 |
Why?
|
| Oxidative Stress | 1 | 2024 | 298 | 0.190 |
Why?
|
| Infant Formula | 1 | 2022 | 12 | 0.190 |
Why?
|
| Metagenomics | 1 | 2022 | 28 | 0.190 |
Why?
|
| Feces | 1 | 2022 | 112 | 0.180 |
Why?
|
| Insulin Resistance | 1 | 2024 | 412 | 0.170 |
Why?
|
| Male | 8 | 2024 | 29891 | 0.170 |
Why?
|
| Liver | 2 | 2024 | 855 | 0.160 |
Why?
|
| Homeodomain Proteins | 1 | 2001 | 268 | 0.160 |
Why?
|
| Trans-Activators | 1 | 2001 | 311 | 0.160 |
Why?
|
| Breast Feeding | 1 | 2022 | 151 | 0.160 |
Why?
|
| Autism Spectrum Disorder | 1 | 2023 | 179 | 0.160 |
Why?
|
| Retrospective Studies | 3 | 2024 | 6658 | 0.150 |
Why?
|
| Pilot Projects | 2 | 2024 | 1008 | 0.150 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 360 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 1 | 2001 | 676 | 0.150 |
Why?
|
| Cohort Studies | 2 | 2024 | 2570 | 0.150 |
Why?
|
| Gene Expression | 1 | 2001 | 840 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 790 | 0.140 |
Why?
|
| Time Factors | 2 | 2017 | 3768 | 0.140 |
Why?
|
| Cooking and Eating Utensils | 1 | 2017 | 1 | 0.140 |
Why?
|
| Single-Blind Method | 1 | 2017 | 144 | 0.130 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2017 | 74 | 0.130 |
Why?
|
| Office Visits | 1 | 2017 | 48 | 0.130 |
Why?
|
| Abdominal Pain | 1 | 2017 | 102 | 0.130 |
Why?
|
| Eating | 1 | 2017 | 138 | 0.130 |
Why?
|
| Biopsy | 1 | 2017 | 443 | 0.120 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 507 | 0.120 |
Why?
|
| Radiography | 1 | 2017 | 550 | 0.120 |
Why?
|
| Treatment Outcome | 3 | 2024 | 5680 | 0.110 |
Why?
|
| Sex Factors | 1 | 2017 | 978 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 978 | 0.110 |
Why?
|
| Hospital-Physician Relations | 1 | 2013 | 3 | 0.100 |
Why?
|
| Delaware | 1 | 2013 | 8 | 0.100 |
Why?
|
| Surveys and Questionnaires | 2 | 2023 | 2681 | 0.100 |
Why?
|
| Laparoscopy | 1 | 2017 | 492 | 0.100 |
Why?
|
| Efficiency, Organizational | 1 | 2013 | 96 | 0.100 |
Why?
|
| Health Care Surveys | 1 | 2013 | 287 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 317 | 0.090 |
Why?
|
| Pediatrics | 1 | 2013 | 255 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2013 | 338 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2013 | 433 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 1644 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1101 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2001 | 456 | 0.050 |
Why?
|
| Adult | 2 | 2023 | 16824 | 0.050 |
Why?
|
| Remission Induction | 1 | 2024 | 148 | 0.050 |
Why?
|
| United States | 1 | 2016 | 7843 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2024 | 369 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2024 | 739 | 0.050 |
Why?
|
| CDX2 Transcription Factor | 1 | 2001 | 5 | 0.050 |
Why?
|
| 5' Flanking Region | 1 | 2001 | 10 | 0.050 |
Why?
|
| 3' Flanking Region | 1 | 2001 | 8 | 0.050 |
Why?
|
| Caco-2 Cells | 1 | 2001 | 70 | 0.050 |
Why?
|
| Enterotoxins | 1 | 2001 | 21 | 0.040 |
Why?
|
| Nucleotides | 1 | 2001 | 49 | 0.040 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2023 | 156 | 0.040 |
Why?
|
| Bacterial Toxins | 1 | 2001 | 61 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2001 | 536 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2001 | 222 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2001 | 392 | 0.040 |
Why?
|
| Middle Aged | 1 | 2016 | 17613 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 1553 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 536 | 0.030 |
Why?
|
| Peptides | 1 | 2001 | 574 | 0.030 |
Why?
|
| Pregnancy | 1 | 2023 | 2334 | 0.030 |
Why?
|
| Escherichia coli Proteins | 1 | 2001 | 271 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2001 | 3035 | 0.010 |
Why?
|